CLEAR ANSWERS · 06 / FAQ
What matters most about BPC-157 TB-500?
These twenty-five answers explain what was tested, what wasn't, and what the drug and sports rules mean. Each answer points to a source.
What the three names mean
Your first BPC-157 TB-500 question may be what these peptides are: they are small pieces of protein, and the short answers below point you to the numbered studies so you can check each fact [1][9].
What does “Wolverine peptide blend” mean?
Wolverine is a research name for BPC-157 paired with TB-500. Some people use “stack” to mean that two substances are taken together. Wolverine has no approval as one drug, and no fixed mixture has been proved in people [9].
What are BPC-157 and TB-500 copied from?
A lab makes BPC-157 from a design based on stomach-juice protein. TB-500 is made in a lab from one section of Thymosin Beta-4, a protein cells use when they travel [3][5]. Wolverine puts those two peptides together.
What did researchers study the separate peptides for?
They tested BPC-157 in animals with injuries to tendons, ligaments, and muscles [1]. Work on Thymosin Beta-4 looked at repair cells moving, skin growing back, and new blood vessels forming [4]. No fair study tested the pair [6].
How is TB-500 different from full Thymosin Beta-4?
TB-500 copies one short part of the full Thymosin Beta-4 protein [5]. Most research chose the full protein rather than its small part. The two forms may not act alike [4][5]. Lab sheets list the TB-500 piece at about 889 daltons. A dalton is a unit used to weigh a molecule, and the whole protein weighs much more. That size gap shows they aren't the same material; it doesn't show whether either form will help or harm you. Unlike BPC-157, TB-500 comes from another protein.
What may BPC-157 and TB-500 do differently?
BPC-157 may help small blood vessels form and help tendon cells receive messages from growth hormone [2]. TB-500 holds actin, a protein cells need for shape and movement [3]. Each finding came from testing one peptide.
Keep track of whether a study used the brief part or the complete protein. Otherwise, TB-500 may get credit for a result that belongs to Thymosin Beta-4.
Why people expect the pair to help in two ways
What is the thinking behind pairing BPC-157 and TB-500?
BPC-157 may bring more blood near an injury [2]. TB-500 may let healing cells reach the injured spot by holding actin [3]. No fair study has shown that those two possible effects lead to more healing when used together [6]. BPC-157 still hasn't been tested as one half of Wolverine, and neither has TB-500.
How may TB-500 affect actin?
TB-500 copies the part of Thymosin Beta-4 that can hold a bit of actin. Cells join actin into strands when they need to change shape or move. An X-ray study showed the whole protein holding a bit of actin apart, which may help a cell control when it builds those strands [3].
How may BPC-157 work in another way?
BPC-157 may help new small blood vessels grow [2]. TB-500 may help cells change shape and travel [3]. Those different possible roles make the pair worth studying. They don't prove it works.
Have both peptides been tied to new blood vessels?
Yes, in early work. BPC-157 increased tiny-vessel growth and restored blood flow in hurt muscle [2]. A review tied the full Thymosin Beta-4 protein to new blood vessels and cell movement [4]. Researchers tested them apart. TB-500 claims still depend on work with the full protein, so that work can't fill the missing trial.
Has a study shown extra help from using both?
No. In 2025, a review gathered 36 BPC-157 studies, but only 1 was a human report. The reviewers found no study that paired BPC-157 with TB-500 [6].
The idea is easy to follow. Work with full Thymosin Beta-4 still doesn't prove that TB-500 will help your injury.
What injury research found in animals but not in people
What did the newest BPC-157 and TB-500 reviews find?
In 2025, one review covered 36 BPC-157 studies. Only 1 was a human report, and the reviewers couldn't find a reliable safety record in people [6]. Another 2025 review found three small early studies of BPC-157 in people [7]. Early studies ask whether larger tests are worth doing; they don't settle whether a treatment works. In 2026, a review found promise in animals but little safety work in people [8].
Has a human trial tested BPC-157 with TB-500?
No fair human trial has tested the pair. Three small early studies looked only at BPC-157 [7]. In human research cited for TB-500, scientists gave full Thymosin Beta-4 [9]. Reviews still describe BPC-157 as a substance being studied [7].
Did BPC-157 TB-500 repair tendons or ligaments in people?
No. BPC-157 helped cut Achilles tendons heal in rats and increased tendon-cell growth in a lab dish [1]. Work on full Thymosin Beta-4 found cell movement and less scar tissue [4]. No human tendon trial tested the blend [6].
Is there study support for muscle recovery?
Only separate work in animals and cells. BPC-157 helped rat tendons and tendon cells [1]. Full Thymosin Beta-4 helped healing cells travel and led to less scar tissue [4]. The TB-500 claim therefore rests on another form of the protein. Wolverine has no human recovery result [9].
Did the BPC-157 TB-500 blend help wounds close?
Animal work on full Thymosin Beta-4 found moving cells, new skin, less scar tissue, and new blood vessels [4]. The blend didn't produce those findings. The TB-500 claim again comes from the full protein. No human wound trial tested the pair [9].
For your choice, keep animal repair clues apart from human proof. The missing BPC-157 TB-500 study matters, and work on Thymosin Beta-4 can't replace it. One raises a question; the other tells what a fair test found in people.
Why animal study numbers can't set a plan for you
Do we know when the body clears BPC-157 and TB-500?
The term half-life means how long the body takes to remove half of a substance. No sound human figure is known for Wolverine. One study in rats and dogs put BPC-157 at under 30 minutes. In the human study, researchers gave full Thymosin Beta-4 and didn't find a time for the short TB-500 piece [9].
What can a 10mg BPC-157 / TB-500 lab label tell you?
Labs may receive dry powder, add clean water, and keep the material cold. They may store the peptides apart or in one vial. The label states an amount in milligrams, but an unregulated label may not match the contents [9]. This tells you how a lab handles material; it isn't a guide for anyone's use.
Did any human trial set a shot schedule for BPC-157 and TB-500?
There is no tested schedule because no human trial studied the blend. Online plans and vials labeled 10 milligrams plus 10 milligrams don't come from fair trials [9]. Amounts tied to an animal's body weight can't become a plan for a person [1].
Has any BPC-157 and TB-500 cycle had a fair test?
No controlled trial has tested a cycle. One stroke study gave rats 18 milligrams of Thymosin Beta-4 for each kilogram of the animal's weight and found no benefit [4]. The failed higher amount gives no support to a larger start.
Study numbers can describe past work. They can't set your own plan.
How harm, sports bans, and pharmacy limits affect your choice
What side effects have human trials of BPC-157 and TB-500 found?
No one has run a fair safety study of Wolverine in people. In 2025, a BPC-157 review found no sound safety record for people [6]. Reviews from 2025-2026 warn that unapproved repair peptides may cause serious harm and may be made outside normal drug checks [7][8]. Long-term safety of the pair is unknown [9].
Could TB-500 help a tumor grow?
The parent protein, Thymosin Beta-4, is found at high levels in several cancers. It may help cells move and small blood vessels form. Both changes can help a tumor spread [4]. That Thymosin Beta-4 research gives you a sound reason to ask your doctor about cancer risk. TB-500 has no human tumor study, and the concern doesn't prove that Wolverine causes cancer in people [9].
Are BPC-157 and TB-500 approved by FDA or allowed in tested sports?
Neither has FDA approval for people, and Wolverine has no approved use [11]. WADA stands for world anti-doping agency, which writes the drug rules used in tested sports. It bans both peptides. BPC-157 is barred because it isn't an approved drug. TB-500 and Thymosin Beta-4 fall under its bans on certain peptides and tissue-repair drugs [5]. FDA put both in Category 2 on September 29, 2023. Its April 22, 2026 page says both requests were withdrawn [11].
Does the law clearly allow a person to use Wolverine?
FDA hasn't approved either BPC-157 or TB-500 as medicine. Both also break WADA rules for tested athletes [5][11]. FDA's April 22, 2026 page marks the requests withdrawn and no longer shows either one in Category 2. Later, FDA staff—the agency's own reviewers—advised against adding them to the list of raw ingredients certain pharmacies may use at the July 23-24 meeting. As of September 2026, FDA had posted no record of the votes [10][11]. Rules may also differ by place and use.
Can a pharmacy make BPC-157 for one patient now?
FDA put BPC-157 in Category 2 in September 2023. The current page says the request was pulled, but it doesn't tell a 503A pharmacy what to do next [11]. A 503A pharmacy is a state-licensed pharmacy that makes medicine for one named patient after a valid prescription. BPC-157 was on the July 23-24, 2026 meeting list for possible addition to the list of ingredients those pharmacies may use [10]. A meeting date isn't an approval.
What does FDA's current 503A record say about BPC-157 TB-500 Wolverine?
FDA put both peptides in Category 2 on September 29, 2023. The current table instead marks both requests withdrawn [11]. The July 23-24, 2026 meeting list included both as possible additions to the 503A ingredient list [10]. The cited record gives no final result.
If you are a tested athlete, keep three questions apart: the sports ban, the pharmacy rule, and what your health makes safe.